Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers
4 Views
administrator
07/06/23
Drs. Jared Weiss and Josh Bauml join GRACE to discuss updates relating to pembrolizumab, nivolumab and and PD-L1 markers for head and neck cancers.
http://cancerGRACE.org/
-
Category
Show more
Facebook Comments
No comments found